Who owns ATHE?
Institutional ownership of Alterity Therapeutics Limited from Form 13F, Q2 2026
22 institutional managers reported holding Alterity Therapeutics Limited (ATHE) in Form 13F filings for Q2 2026, with 394,548 shares worth $2.1M. The largest reported holder was Twin Lakes Capital Management, LLC. Managers that filed both quarters added a net 73,715 shares (+23.0%). 7 opened new positions and 0 sold out.
- Funds holding
- 22
- Value held
- $2.1M
- New / sold out
- 7 / 0
- Net shares, same filers
- +23.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ATHE
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Twin Lakes Capital Management, LLC | $748K | 35.3% | 139,258 | Unchanged |
| Morgan Stanley | $339K | 16.0% | 63,065 | Added |
| Greenleaf Trust | $333K | 15.7% | 62,000 | Added |
| HB Wealth Management, LLC | $314K | 14.8% | 58,460 | Unchanged |
| Citadel Advisors LLC | $202K | 9.5% | 37,597 | Added |
| HRT Financial LP | $92K | 4.4% | 17,292 | New |
| BNP Paribas Financial Markets | $55K | 2.6% | 10,239 | Added |
| GAMMA Investing LLC | $12K | 0.6% | 2,309 | Added |
| Rhumbline Advisers | $11K | 0.5% | 2,009 | Added |
| Acadian Asset Management LLC | $10K | 0.5% | 1,863 | Unchanged |
| Providence Capital Advisors, LLC | $1K | 0.1% | 200 | New |
| Integrated Wealth Concepts LLC | $392 | 0.0% | 73 | New |
| Osaic Holdings, Inc. | $362 | 0.0% | 68 | Unchanged |
| Blue Trust, Inc. | $215 | 0.0% | 40 | Unchanged |
| Farther Finance Advisors, LLC | $205 | 0.0% | 39 | Added |
| CoreCap Advisors, LLC | $113 | 0.0% | 21 | Unchanged |
| Steward Partners Investment Advisory, LLC | $32 | 0.0% | 6 | Unchanged |
| UBS Group AG | $27 | 0.0% | 5 | New |
| Cranbrook Wealth Management, LLC | $6 | 0.0% | 1 | New |
| Caitong International Asset Management Co., Ltd | $5 | 0.0% | 1 | New |
| Citigroup Inc | $5 | 0.0% | 1 | New |
| Danske Bank A/S | $5 | 0.0% | 1 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 394,548 ATHE shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Greenleaf Trust Added+$161K
- Citadel Advisors LLC Added+$94K
- HRT Financial LP New+$92K
- Morgan Stanley Added+$25K
- BNP Paribas Financial Markets Added+$18K
- GAMMA Investing LLC Added+$2K
- Providence Capital Advisors, LLC New+$1K
- Integrated Wealth Concepts LLC New+$392
- Rhumbline Advisers Added+$209
- Farther Finance Advisors, LLC Added+$89
Biggest sellers in Q2 2026
None reported.
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $395K and sold $0; 7 added and 0 trimmed.
Schedule 13D and 13G filings on ATHE
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-05-02JPMORGAN CHASE & CO SCHEDULE 13G filed by Alterity Therapeutics LimitedSchedule 13G
Questions about ATHE ownership
- Who owns ATHE stock?
- 22 institutional investment managers reported ATHE positions in their Form 13F filings for Q2 2026, holding 394,548 shares worth $2.1M in total. Twin Lakes Capital Management, LLC reported the largest position.
- Are funds buying or selling ATHE?
- In Q2 2026, 7 managers opened new ATHE positions, 7 added, 0 trimmed and 0 sold out. Managers that filed in both quarters added a net 73,715 shares.
- How current is this ATHE institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ATHE by CUSIP. Options are left out. ATHE news and filings · ATHE insider trades · Top funds